HIGHLIGHTS
- who: Ross M. Kedl from the development of multiple safe and efficacious vaccines in recordbreaking timeModerna performed its phase III COVE (COronaVirus Efficacy) study of its vaccine, m, at the University of have published the article: An immunological autobiography: my year as a COVID-19 vaccine trial participant, in the Journal: (JOURNAL) of 19/01/2022
- how: I also examined saliva and nasal swab samples for the presence of anti-SARS-CoV2-specific IgG and IgA as published data indicated that antibodies could indeed be found in these sites following mRNA_vaccination5-8.
- future . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.